JPH0438398B2 - - Google Patents
Info
- Publication number
- JPH0438398B2 JPH0438398B2 JP1291584A JP1291584A JPH0438398B2 JP H0438398 B2 JPH0438398 B2 JP H0438398B2 JP 1291584 A JP1291584 A JP 1291584A JP 1291584 A JP1291584 A JP 1291584A JP H0438398 B2 JPH0438398 B2 JP H0438398B2
- Authority
- JP
- Japan
- Prior art keywords
- amino
- acid
- phenylbutyric acid
- phenylbutyric
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- PPKAIMDMNWBOKN-UHFFFAOYSA-N 2-Oxo-4-phenylbutyric acid Chemical compound OC(=O)C(=O)CCC1=CC=CC=C1 PPKAIMDMNWBOKN-UHFFFAOYSA-N 0.000 claims description 12
- 244000005700 microbiome Species 0.000 claims description 8
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- 229960005261 aspartic acid Drugs 0.000 claims description 6
- JTTHKOPSMAVJFE-UHFFFAOYSA-N 2-azaniumyl-4-phenylbutanoate Chemical compound OC(=O)C(N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-UHFFFAOYSA-N 0.000 claims description 5
- 241000590020 Achromobacter Species 0.000 claims description 5
- 241000589291 Acinetobacter Species 0.000 claims description 5
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 5
- 150000008575 L-amino acids Chemical class 0.000 claims description 5
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 4
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- 229960003767 alanine Drugs 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241001057811 Paracoccus <mealybug> Species 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229960002989 glutamic acid Drugs 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 10
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 4
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000589597 Paracoccus denitrificans Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- -1 ammonium fumarate Chemical class 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000011790 ferrous sulphate Substances 0.000 description 3
- 235000003891 ferrous sulphate Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229950009215 phenylbutanoic acid Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 235000008206 alpha-amino acids Nutrition 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 2
- 235000019838 diammonium phosphate Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 2
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 2
- 229960001327 pyridoxal phosphate Drugs 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000004716 alpha keto acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 108010003977 aminoacylase I Proteins 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明はL−2−アミノ−4−フエニル酪酸の
製法に関する。
本発明の目的化合物L−2−アミノ−4−フエ
ニル酪酸は医薬品原料として重要な物質であり、
又必須アミノ酸L−フエニルアラニンの類似化合
物として生化学分野で種々の用途を有する有用な
物質である。
従来、L−2−アミノ−4−フエニル酪酸の製
法としては、化合的に合成されたDL−2−アミ
ノ−4−フエニル酪酸を光学分割する方法(V.
Du Vigneaud and O.J.Irish.J.Biol.Chem.122349
(1938))等が知られているが、これらの方法は収
率や操作の点で問題があり、工業的に有利な方法
とは言い難い。一方、α−ケト酸を生化学的に直
接α−アミノ酸に変換する代表的な方法として
は、例えば酵素を利用して還元的にアミノ化する
方法或は他のα−アミノ酸のアミノ基を転移させ
る方法等があるが、かかる生化学反応を利用する
場合には、例えばピルピン酸をL−アラニンに変
換させる酵素はオキサル酢酸を殆んどの場合L−
アスパラギン酸へ変化させない等、使用酵素に通
常高い基質特異性が認められる。それ故、生体内
物質の化学変化にはその反応を触媒する酵素が存
在するとしても、生体内物質ではない2−オキソ
−4−フエニル酪酸を処理するに際し、かかる生
化学的手法を利用しうるか否かは、同化合物をL
−2−アミノ−4−フエニル酪酸の転換せしめる
酵素がこれまで発見されていないことからも、従
来全く予測しえなかつた。
かかる状況に鑑み鋭意研究を重ねた結果、本発
明者らはある種の微生物に2−オキソ−4−フエ
ニル酪酸をL−2−アミノ−4−フエニル酪酸へ
転換せしめる酵素の存在することを見出し、本発
明を完成するに至つた。
即ち、本発明によれば、L−2−アミノ−4−
フエニル酪酸はアクロモバクター
(Achromobacter)属、アシネトバクター
(Acinetobacter)属、バチルス(Bacillus)属、
パラコツカス(Paracoccus)属に属し、2−オ
キソ−4−フエニル酪酸からL−2−アミノ−4
−フエニル酪酸を生成せしめる能力を有する微生
物の培養液、該培養液から得た菌体又は菌体処理
物をL−アミノ酸存在下2−オキソ−4−フエニ
ル酪酸に作用させることにより製造することがで
きる。
本発明に使用する微生物としてはアクロモバク
ター属、アシネトバクター属、バチルス属、パラ
コツカス属に属し、2−オキソ−4−フエニル酪
酸からL−2−アミノ−4−フエニル酪酸を生成
せしめる能力を有するものであればいずれも使用
でき、例えばアクロモバクター、リキダム
(Achrombacter liquidum)OUT 8012(微工研
菌寄第12684号)、アシネトバクター、カルコアセ
チカス(Acinetobacter calcoacetics)IFO
12552、バチルス・セレウス(Bacillus cereus)
IFO 3001、パラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442等が好適
に挙げられる。
上記微生物の培養は通常の条件下で行うことが
できる。即ち、栄養培地の炭素源としては、上記
微生物の利用可能なものであればいずれも使用で
き、例えば、グルコース、フルクトース、シユク
ロース、マルトース、デキストリン等の糖類、グ
リセロース、ソルビトール等の糖アルコール、フ
マール酸、クエン酸等の有機酸を使用することが
できる。培地への添加量は通常、0.1〜10%程度
とするのが好ましい。窒素源としては、例えば塩
化アンモニウム、硫酸アンモニウム、リン酸アン
モニウム等の無機酸のアンモニウム塩、フマール
酸アンモニウム等の有機酸のアンモニウム塩、肉
エキス、酵母エキス、コーンステープリカー、カ
ゼイン加水分解物等の天然有機窒素源等を使用す
ることができ、このうち有機窒素源は多くの場
合、炭素源として兼用することもできる。窒素源
の添加量は通常、0.1〜10%の範囲が好適である。
また、無機塩類としては例えば、リン酸カリウ
ム、リン酸ナトリウムの如きリン酸アルカリ金
属、塩化カリウム、塩化ナトリウムの如き塩化ア
ルカリ金属、硫酸マグネシウム、硫酸第一鉄の如
き、金属硫酸塩等を好適に使用することができ、
その使用量は通常、0.001〜1%の範囲が好適で
ある。微生物の培養にはPH約5〜8、20〜40℃
で、とりわけPH約6〜7、30〜37℃で好気的条件
下に実施するのが好ましい。
次いで、上記の如くして得られた培養液、該培
養液より得た菌体又は該菌体の処理物を酵素源と
し、これをL−アミノ酸の存在下基質である2−
オキソ−4−フエニル酪酸に作用させることによ
りL−2−アミノ−4−フエニル酪酸を製するこ
とができる。培養液より得た菌体としては例え
ば、遠心分離、過等により分離された菌体が挙
げられ、菌体の処理物としては凍結乾燥菌体、ア
セトン乾燥菌体、洗浄菌体、菌体磨砕物、菌体の
自己消化物、菌体の超音波処理物、菌体抽出物又
はこれらをゲル抱括法や吸着法等のそれ自体公知
の固定化方法により固定化したものが挙げられ
る。固定化したものの具体例としては培養液、菌
体ないし菌体処理物を例えばポリアクリルアミド
ゲル、含硫多糖類ゲル(カラギーナン、フアーセ
レラン等)、コラーゲンゲル、アルギン酸ゲル、
ポリビニルアルコールゲル、寒天ゲル等で固定し
たものが挙げられる。さらに本発明の酵素源たる
菌体処理物としては菌体抽出物から公知の方法を
組合せて精製・採取した酵素をそれ自体も使用す
ることができる。
該反応は培養液の菌体を含む培養液に基質を加
えて実施してもよく、又該培養液より得た菌体又
は該菌体処理物を基質の水溶液に加えて反応させ
てもよい。上記本反応に用いるL−アミノ酸とし
ては例えば、L−アスパラギン酸、L−グルタミ
ン酸又はL−アラニン等があげられ、基質に対し
て当モル以上用いるのが好ましい。
また、反応時間の短縮或いはL−2−アミノ−
4−フエニル酪酸の蓄積量の増加をはかるために
は界面活性剤及び/又は補酵素等の存在下に実施
するのが好ましい。この目的に用いうる界面活性
剤としては例えば、臭化セチルトリメチルアンモ
ニウム、ポリエチレングリコール、p−イソオク
チルフエニルエーテル(ローム アンド ハース
社製 商品名:トリトン X−100)等を用いる
ことができ、その使用量は反応液に対し0.0001〜
0.1%程度とするのが好ましい。又、上記目的に
用いうる補酵素としては例えば、ピリドキサール
リン酸を挙げることができ、概ね反応液に対して
0.001〜1mM程度の濃度で用いるのが好ましい。
このようにして反応液中に蓄積したL−2−ア
ミノ−4−フエニル酪酸はそれ自体は水に殆ど不
溶であり、過又は遠心分離等通常の手段を用い
て容易に反応液から分離・採取することができ
る。また、L−2−アミノ−4−フエニル酪酸は
酸又はアルカリ性塩にすると水に可溶性となるた
め、反応液に酸又はアルカリを加え過して不純
物を除き、液を中和してL−2−アミノ−4−
フエニル酪酸結晶を析出させた後、過、遠心分
離等の常法で反応液から分離・採取することもで
きる。
以下、実施例を挙げて本発明を具体例に説明す
る。
尚、実施例中の2−オキソ−4−フエニル酪酸
及びL−2−アミノ−4−フエニル酪酸の定量は
液体クロマトグラフイー法により行ない、L−2
−アミノ−4−フエニル酪酸の確認は取得結晶の
元素分析値並びに予め合成したN−アセチル−
DL−2−アミノ−4−フエニル酪酸に市販のア
ミノアシラーゼを作用させて製したL−2−アミ
ノ−4−フエニル酪酸と比旋光度、NMR及びIR
スペクトルを比較する等して行なつた。本明細書
中”%”はいずれも”重量/容量(g/ml)”を
意味するものとする。
実施例 1
(1) グルコース1%、カゼイン加水分解物1%、
酵母エキス1%、リン酸水素2アンモニウム
0.2%、リン酸2水素カリウム0.1%、硫酸マグ
ネシウム0.05%、硫酸第1鉄0.001%、塩化カ
ルシウム0.01%及びカラリン102(三洋化成工業
株式会社製商品名)0.003%から成る培地50ml
(PH7.0)を120℃で10分間滅菌した。該培地に
パラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442を1白
金耳接種後、30℃で18時間振盪培養した。培養
後、培養液を遠心分離して集菌した後、菌体を
凍結乾燥することにより、凍結乾燥菌体0.5g
を調製した。
(2) 2−オキソ−4−フエニル酪酸4g、L−ア
スパラギン酸3.2g及びピリドキサールリン酸
0.003gを水に溶解し、アンモニア水でPH8.5と
した後、水を加えて全体を100mlとした基質溶
液に上記(1)で調製した凍結乾燥菌体1gを加え
30℃で2日間反応させた。該反応液に塩酸を加
えて生成物を溶解させ、活性炭2gを加えて吸
引過した。液を水酸化ナトリウムで中和
し、析出した結晶を取することによりL−2
−アミノ−4−フエニル酪酸3.1gを得た。収
率78%
融点:286〜288℃(分解)
〔α〕22 D+47℃(C=1、1N−HCl)
実施例2〜4
実施例1−(1)と同様にして下記第1表に示す微
生物を培養し、その培養液100mlから遠心分離に
よつて集菌した菌体を基質溶液(2−オキソ−4
−フエニル酪酸4g、L−アスパラギン酸3.2g、
臭化セチルトリメチルアンモニウム10mgを100ml
の水に溶解し、水酸化ナトリウム水溶液でPH8.5
として調製)に懸濁した。この懸濁液を30℃で2
日間反応させることにより、L−2−アミノ−4
−フエニル酪酸が得られた。結果は下記表に示す
通りである。
The present invention relates to a method for producing L-2-amino-4-phenylbutyric acid. The target compound of the present invention, L-2-amino-4-phenylbutyric acid, is an important substance as a pharmaceutical raw material,
It is also a useful substance that has various uses in the biochemical field as a similar compound to the essential amino acid L-phenylalanine. Conventionally, L-2-amino-4-phenylbutyric acid has been produced by optically resolving chemically synthesized DL-2-amino-4-phenylbutyric acid (V.
Du Vigneaud and OJIrish.J.Biol.Chem. 122 349
(1938)), but these methods have problems in terms of yield and operation, and cannot be said to be industrially advantageous. On the other hand, typical methods for directly biochemically converting α-keto acids into α-amino acids include reductive amination using enzymes or transfer of the amino group of other α-amino acids. However, when such a biochemical reaction is used, for example, the enzyme that converts pyrupic acid to L-alanine converts oxalacetic acid into L-alanine in most cases.
The enzyme used usually has high substrate specificity, such as not converting it to aspartic acid. Therefore, even though there are enzymes that catalyze chemical changes in biological substances, it is not possible to use such biochemical methods to treat 2-oxo-4-phenylbutyric acid, which is not a biological substance. Whether or not the same compound is L
This was completely unpredictable since no enzyme that converts -2-amino-4-phenylbutyric acid has been discovered so far. As a result of extensive research in view of this situation, the present inventors discovered that certain microorganisms contain an enzyme that converts 2-oxo-4-phenylbutyric acid to L-2-amino-4-phenylbutyric acid. , we have completed the present invention. That is, according to the present invention, L-2-amino-4-
Phenylbutyric acid is derived from the genus Achromobacter, genus Acinetobacter, genus Bacillus,
Belongs to the genus Paracoccus, and produces L-2-amino-4 from 2-oxo-4-phenylbutyric acid.
- It can be produced by allowing a culture solution of a microorganism capable of producing phenylbutyric acid, bacterial cells obtained from the culture solution, or a processed product of the bacterial cells to act on 2-oxo-4-phenylbutyric acid in the presence of L-amino acids. can. The microorganisms used in the present invention belong to the genus Achromobacter, Acinetobacter, Bacillus, and Paracoccus, and have the ability to produce L-2-amino-4-phenylbutyric acid from 2-oxo-4-phenylbutyric acid. Any of them can be used, such as Achromobacter, Achromobacter liquidum OUT 8012 (Feikoken Bibori No. 12684), Acinetobacter, Acinetobacter calcoacetics IFO
12552, Bacillus cereus
Preferred examples include IFO 3001 and Paracoccus denitrificans IFO 12442. The above microorganisms can be cultured under normal conditions. That is, as a carbon source for the nutrient medium, any carbon source that can be used by the above-mentioned microorganisms can be used, such as sugars such as glucose, fructose, sucrose, maltose, and dextrin, sugar alcohols such as glycerose and sorbitol, and fumaric acid. Organic acids such as , citric acid and the like can be used. The amount added to the medium is usually preferably about 0.1 to 10%. Examples of nitrogen sources include ammonium salts of inorganic acids such as ammonium chloride, ammonium sulfate, and ammonium phosphate, ammonium salts of organic acids such as ammonium fumarate, and natural sources such as meat extract, yeast extract, corn staple liquor, and casein hydrolyzate. An organic nitrogen source can be used, and in many cases, the organic nitrogen source can also be used as a carbon source. The amount of nitrogen source added is usually preferably in the range of 0.1 to 10%.
Preferred examples of inorganic salts include alkali metal phosphates such as potassium phosphate and sodium phosphate, alkali metal chlorides such as potassium chloride and sodium chloride, metal sulfates such as magnesium sulfate, and ferrous sulfate. can be used,
The amount used is usually preferably in the range of 0.001 to 1%. For culturing microorganisms, pH is approximately 5-8, 20-40℃
In particular, it is preferably carried out under aerobic conditions at a pH of about 6-7 and 30-37°C. Next, the culture fluid obtained as described above, the bacterial cells obtained from the culture fluid, or the processed product of the bacterial cells are used as an enzyme source, and this is used as an enzyme source in the presence of L-amino acids.
L-2-amino-4-phenylbutyric acid can be produced by acting on oxo-4-phenylbutyric acid. Examples of bacterial cells obtained from a culture solution include bacterial cells separated by centrifugation, filtration, etc., and processed bacterial cells include freeze-dried bacterial cells, acetone-dried bacterial cells, washed bacterial cells, and bacterial cell polishing. Examples include crushed materials, autolysed bacterial cells, ultrasonicated bacterial cells, bacterial cell extracts, and those obtained by immobilizing these by a known immobilization method such as a gel entrapment method or an adsorption method. Specific examples of immobilized materials include culture solutions, bacterial cells, or treated bacterial cells, such as polyacrylamide gels, sulfur-containing polysaccharide gels (carrageenan, fur-cerelan, etc.), collagen gels, alginate gels,
Examples include those fixed with polyvinyl alcohol gel, agar gel, etc. Furthermore, as the enzyme source of the present invention, an enzyme purified and collected from a bacterial cell extract by a combination of known methods can also be used. The reaction may be carried out by adding a substrate to a culture solution containing microbial cells, or the microbial cells obtained from the culture solution or the processed product of the microbial cells may be added to an aqueous solution of the substrate and the reaction may be carried out. . Examples of the L-amino acid used in the above-mentioned main reaction include L-aspartic acid, L-glutamic acid, and L-alanine, and it is preferable to use at least an equivalent molar amount to the substrate. In addition, shortening of reaction time or L-2-amino-
In order to increase the amount of 4-phenylbutyric acid accumulated, it is preferable to carry out the reaction in the presence of a surfactant and/or a coenzyme. Examples of surfactants that can be used for this purpose include cetyltrimethylammonium bromide, polyethylene glycol, and p-isooctyl phenyl ether (trade name: Triton X-100, manufactured by Rohm and Haas). The amount used is 0.0001~ relative to the reaction solution.
It is preferably about 0.1%. In addition, as a coenzyme that can be used for the above purpose, for example, pyridoxal phosphate can be mentioned, and it is generally
It is preferable to use it at a concentration of about 0.001 to 1 mM. The L-2-amino-4-phenylbutyric acid accumulated in the reaction solution in this way is almost insoluble in water and can be easily separated and collected from the reaction solution using conventional means such as filtration or centrifugation. can do. In addition, since L-2-amino-4-phenylbutyric acid becomes soluble in water when made into an acid or alkaline salt, an acid or alkali is added to the reaction solution to remove impurities and the solution is neutralized. -amino-4-
After phenylbutyric acid crystals are precipitated, they can be separated and collected from the reaction solution by conventional methods such as filtration or centrifugation. Hereinafter, the present invention will be specifically explained with reference to Examples. In addition, the quantitative determination of 2-oxo-4-phenylbutyric acid and L-2-amino-4-phenylbutyric acid in the examples was carried out by liquid chromatography.
-Amino-4-phenylbutyric acid was confirmed using the elemental analysis values of the obtained crystals and the pre-synthesized N-acetyl-
L-2-amino-4-phenylbutyric acid produced by reacting commercially available aminoacylase with DL-2-amino-4-phenylbutyric acid and specific rotation, NMR and IR
This was done by comparing spectra. In this specification, "%" means "weight/volume (g/ml)". Example 1 (1) 1% glucose, 1% casein hydrolyzate,
Yeast extract 1%, diammonium hydrogen phosphate
0.2%, potassium dihydrogen phosphate 0.1%, magnesium sulfate 0.05%, ferrous sulfate 0.001%, calcium chloride 0.01%, and Calalin 102 (trade name manufactured by Sanyo Chemical Industries, Ltd.) 0.003%.
(PH7.0) was sterilized at 120°C for 10 minutes. One platinum loop of Paracoccus denitrificans IFO 12442 was inoculated into the medium, and cultured with shaking at 30°C for 18 hours. After culturing, the culture solution is centrifuged to collect bacteria, and the cells are freeze-dried to obtain 0.5 g of freeze-dried cells.
was prepared. (2) 4g of 2-oxo-4-phenylbutyric acid, 3.2g of L-aspartic acid and pyridoxal phosphate
Dissolve 0.003g in water, adjust the pH to 8.5 with aqueous ammonia, add water to make a total of 100ml, and add 1g of the freeze-dried bacterial cells prepared in (1) above to the substrate solution.
The reaction was carried out at 30°C for 2 days. Hydrochloric acid was added to the reaction solution to dissolve the product, 2 g of activated carbon was added, and the mixture was filtered under suction. By neutralizing the liquid with sodium hydroxide and collecting the precipitated crystals, L-2
3.1 g of -amino-4-phenylbutyric acid was obtained. Yield 78% Melting point: 286-288°C (decomposition) [α] 22 D +47°C (C = 1, 1N-HCl) Examples 2 to 4 In the same manner as Example 1-(1), the results are shown in Table 1 below. The microorganisms shown were cultured, and the bacterial cells collected from 100 ml of the culture solution by centrifugation were added to a substrate solution (2-oxo-4
-4 g of phenylbutyric acid, 3.2 g of L-aspartic acid,
Cetyltrimethylammonium bromide 10mg to 100ml
Dissolved in water, pH8.5 with sodium hydroxide aqueous solution
(prepared as ). This suspension was heated at 30℃ for 2 hours.
By reacting for several days, L-2-amino-4
-Phenylbutyric acid was obtained. The results are shown in the table below.
【表】
実施例 5
グルコース100g、カゼイン加水分解物150g、
コーンステープリカー50g、酵母エキス100g、
リン酸水素2アンモニウム20g、リン酸水素2カ
リウム10g、硫酸マグネシウム5g、硫酸第1鉄
0.1g、塩化カシンウム1g、カラリン102(三洋
化成工業株式会社製商品名)0.3g及び水10か
ら成る培地(PH7.0)を丸菱株式会社製MSJ−u
型20容ジヤーフアメンターに仕込み120℃で10
分間滅菌した。該培地に30℃で18時間振盪下フラ
スコ培養したパラコツカス・デニトリフイカンス
(Paracoccus denitrificans)IFO 12442の菌体液
100mlを接種し、1/2vwm、400rpm、30℃で20
時間培養した。次いで、該培養液に2−オキソ−
4−フエニル酪酸400g、L−アスパラギン酸320
g、臭化セチルトリメチルアンモニウム1gを加
え、アンモニア水でPH8.5に調整した後、37℃で
2日間反応させた。2日後培養液中には、2−オ
キソ−4−フエニル酪酸が認められず、L−2−
アミノ−4−フエニル酪酸360gが生成蓄積して
いた。遠心過機で該反応液から菌体及び培養液
等の不純物を除き、残存結晶を純水に懸濁して洗
浄することにより、L−2−アミノ−4−フエニ
ル酪酸の結晶320gを得た。収率79.5%。[Table] Example 5 100g of glucose, 150g of casein hydrolyzate,
50g corn staple liquor, 100g yeast extract,
Diammonium hydrogen phosphate 20g, dipotassium hydrogenphosphate 10g, magnesium sulfate 5g, ferrous sulfate
A medium (PH7.0) consisting of 0.1 g, 1 g of calcium chloride, 0.3 g of Calalin 102 (trade name manufactured by Sanyo Chemical Industries, Ltd.) and 10 g of water was added to MSJ-u manufactured by Marubishi Corporation.
Pour into a 20 volume jar fermentor and heat at 120℃ for 10 minutes.
Sterilized for minutes. Cell fluid of Paracoccus denitrificans IFO 12442 cultured in a flask under shaking at 30°C for 18 hours in this medium.
Inoculate 100ml and inoculate at 1/2vwm, 400rpm, 30℃ for 20
Cultured for hours. Next, 2-oxo-
4-phenylbutyric acid 400g, L-aspartic acid 320g
After adding 1 g of cetyltrimethylammonium bromide and adjusting the pH to 8.5 with aqueous ammonia, the mixture was reacted at 37°C for 2 days. 2-oxo-4-phenylbutyric acid was not observed in the culture solution after 2 days, and L-2-
360 g of amino-4-phenylbutyric acid was produced and accumulated. Impurities such as bacterial cells and culture fluid were removed from the reaction solution using a centrifuge, and the remaining crystals were suspended in pure water and washed to obtain 320 g of crystals of L-2-amino-4-phenylbutyric acid. Yield 79.5%.
Claims (1)
アミノ−4−フエニル酪酸を生成せしめる能力を
有するアクロモバクター属、アシネトバクター
属、バチルス属又はパラコツカス属微生物の培養
液、該培養液から得た菌体又は該菌体の処理物を
L−アミノ酸の存在下2−オキソ−4−フエニル
酪酸に作用させ、生成したL−2−アミノ−4−
フエニル酪酸を採取することを特徴とするL−2
−アミノ−4−フエニル酪酸の製法。 2 L−アミノ酸がL−アスパラギン酸、L−グ
ルタミン酸又はL−アラニンである特許請求の範
囲第1項記載の製法。[Claims] 1 2-oxo-4-phenylbutyric acid to L-2-
A culture solution of a microorganism of the genus Achromobacter, Acinetobacter, Bacillus or Paracoccus that has the ability to produce amino-4-phenylbutyric acid, cells obtained from the culture solution, or a processed product of the cells are used to produce L-amino acids. 2-oxo-4-phenylbutyric acid in the presence of L-2-amino-4-
L-2 characterized by collecting phenylbutyric acid
-Production method of amino-4-phenylbutyric acid. 2. The production method according to claim 1, wherein the L-amino acid is L-aspartic acid, L-glutamic acid, or L-alanine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1291584A JPS60156394A (en) | 1984-01-26 | 1984-01-26 | Preparation of l-2-amino-4-phenylbutyric acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1291584A JPS60156394A (en) | 1984-01-26 | 1984-01-26 | Preparation of l-2-amino-4-phenylbutyric acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60156394A JPS60156394A (en) | 1985-08-16 |
| JPH0438398B2 true JPH0438398B2 (en) | 1992-06-24 |
Family
ID=11818638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1291584A Granted JPS60156394A (en) | 1984-01-26 | 1984-01-26 | Preparation of l-2-amino-4-phenylbutyric acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60156394A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0787778B2 (en) * | 1987-12-10 | 1995-09-27 | 田辺製薬株式会社 | Novel microorganism and method for producing L-amino acid using the same |
| US5665508A (en) * | 1991-07-23 | 1997-09-09 | Minolta Camera Kabushiki Kaisha | Electrophotography carrier having domains dispersed in a matrix resin with a dispersion assistant interposed |
-
1984
- 1984-01-26 JP JP1291584A patent/JPS60156394A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60156394A (en) | 1985-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0249188B1 (en) | Process for the production of L-2-amino-4-(hydroxymethyl-phosphinyl)-butyric acid | |
| US4080259A (en) | Process of preparing L and D α-amino acids by enzyme treatment of DL-α-amino acid amide | |
| JPH0693839B2 (en) | Method for producing L-2-amino-4- (hydroxymethylphosphinyl) butyric acid | |
| JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
| JP2950896B2 (en) | Method for producing D-α-phenylglycine | |
| JPH0411194B2 (en) | ||
| JPS6129953B2 (en) | ||
| JPH0928390A (en) | Microbiological production method of glycolic acid | |
| JPH0438398B2 (en) | ||
| JPH01320991A (en) | Production of d-homophenylalanines | |
| EP0187525B1 (en) | Process for producing l-serine | |
| JPH0148758B2 (en) | ||
| JPH03277292A (en) | Production of optically active 2-hydroxycarboxylic acid | |
| JP2924679B2 (en) | Production method of D-lysine | |
| WO1996031616A1 (en) | Process for producing l-2-aminoadipic acid | |
| JPH1042886A (en) | Method for producing β-alanine by microorganism | |
| JP2674078B2 (en) | Process for producing D-α-amino acid | |
| JP2899071B2 (en) | Method for producing L-α-alanine | |
| JPH03112490A (en) | Production of l-homophenylalanine | |
| JP2674076B2 (en) | Method for producing D-α-amino acid | |
| JPS6225353B2 (en) | ||
| JPH0630572B2 (en) | L-phenylalanine dehydrogenase | |
| JPH03112491A (en) | Production of l-homophenylalanine | |
| JPH07250694A (en) | Production of l-2-amino-4-(hydroxymethylphosphinyl)-butyric acid | |
| JPH0533039B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |